http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2843941-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27de85b769c5a78e1672e6e5d0d5068e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-037
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12109
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D175-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D167-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
filingDate 2014-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e4a281c874e0c242f8f3374cb489fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99e915dae125e2e2cbdb5cf9b2f97cb
publicationDate 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2843941-A1
titleOfInvention Method of fabricating modifiable occlusion device
abstract A method of fabricating a frangible material for an occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, including selecting first and second spray devices having first and second nozzle openings and first and second adjustable flow controls, respectively. The first and second spray devices are arranged to deliver droplets of a first liquid including at least one biocompatible polymer through the first spray device and to deliver droplets of a second liquid including a non-solvent for the polymer through the second spray device in an overlapping spray pattern on a substrate at a pre-selected distance and a pre-selected relative translation speed.
priorityDate 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952

Total number of triples: 39.